pros and cons of glp-1 medications & weight loss drugs GLP-1 Agonists For Obesity In

Furthermore, GLP-1 receptor agonists induce anti-inflammatory effects that could attenuate the low-grade inflammation that underlies obesity, PsO, and HS (reviewed recently in the context of PsO and psoriatic arthritis).68 Finally, improved metabolic control and cardio-renal protection could be beneficial for reducing CVR and managing comorbidities such as DT2 or metabolic syndrome

Schedule an appointment.

Adopting habits like eating a balanced diet, staying active, and managing stress can amplify the weight loss effects of these medications while boosting overall metabolic health

These include IDegLira from Novo Nordisk, combining Tresiba (insulin degludec) and Victoza (liraglutide) into a once-daily injectable product ( and iGlarLixi from Sanofi, combining Lantus (insulin glargine) and Lyxumia (lixisenatide) into a similar product ( Both of the component drugs in IDegLira and the insulin glargine in iGlarLixi are already FDA approved, whereas lixisenatide is currently undergoing independent regulatory review

By collaborating with the patient, I can tailor the treatment plan to suit their unique situation

It is not just a number on a scale